FDA Approved: * September 13, 2011 Pharm Company: *AMNEAL PHARMS Category:Anticonvulsant
Felbamate (marketed under the brand name Felbatol by MedPointe) is an anticonvulsant used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox–Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drug's usage to severe refractory epilepsy.
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion